For instance, in February 2023, according to Diabetes Canada, a Canada-based non-profit organization, in 2023, approximately 2.4 million people in Canada lived with diabetes or prediabetes, and this number is projected to rise to 3 million by 2033
Os anlogos de GLP-1 so uma classe de medicamentos originalmente desenvolvidos para tratar diabetes tipo 2, mas que tambm demonstram eficcia no tratamento da obesidade
Dosage: The recommended dosage depends on your skin type, goals, and medical history
Both drugs contain semaglutide, a synthetic version of a hormone known as GLP-1, which the body releases into the intestine when people eat food, reducing feelings of hunger
"In recent weeks, Novo Nordisks commercial team increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients